ArticleJournal of neurology2024

Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.

Andreas R Gantenbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.